RS Research
1 known investors
RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
PR
Prof. Rana SanyalCo-Founder
Investors Β· 1
Frequently asked questions
- What does RS Research do?
- RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
- Who founded RS Research?
- RS Research was founded by Prof. Rana Sanyal.
- Who are RS Research's investors?
- RS Research's investors include ACT Venture Partners.